Ainos, Inc. is a Texas-incorporated dual-platform company advancing AI-based scent digitization technologies and immune therapeutics. Its core platform, AI Nose, integrates gas sensor arrays with proprietary smell language model (SLM) AI to digitize volatile organic compound signals into machine-readable Smell ID data for industrial and healthcare applications. The company also develops VELDONA, a low-dose oral interferon alpha formulation targeting rare, autoimmune, and infectious disease indications, and has commercialized VELDONA Pet supplements in Taiwan.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013579 | EDGAR | 58K words |
| 2025-03-07 | 2024-12-31 | 0001493152-25-009568 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001654954-24-002897 | EDGAR | — |
| 2023-04-03 | 2022-12-31 | 0001654954-23-004157 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0001654954-22-003463 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001654954-21-003517 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001437749-20-006575 | EDGAR | — |
| 2019-04-16 | 2018-12-31 | 0001014763-19-000004 | EDGAR | — |
| 2018-04-18 | 2017-12-31 | 0001014763-18-000004 | EDGAR | — |
| 2017-04-17 | 2016-12-31 | 0001014763-17-000003 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022312 | EDGAR | 20K words |
| 2025-08-13 | 2025-06-30 | 0001493152-25-011908 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010264 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001493152-24-043832 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0001493152-24-030251 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018885 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001654954-23-014023 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001654954-23-010601 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001654954-23-006377 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001654954-22-015091 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001654954-22-011233 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001654954-22-006967 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001493152-26-013578 | EDGAR | 2K words |
| 2026-01-06 | 0001493152-26-000517 | EDGAR | — |
| 2026-01-05 | 0001493152-26-000271 | EDGAR | — |
| 2025-12-31 | 0001493152-25-029794 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022311 | EDGAR | — |
| 2025-10-17 | 0001493152-25-018460 | EDGAR | — |
| 2025-09-08 | 0001493152-25-012781 | EDGAR | — |
| 2025-08-13 | 0001641172-25-023515 | EDGAR | — |
| 2025-08-07 | 0001493152-25-011679 | EDGAR | — |
| 2025-07-31 | 0001493152-25-011520 | EDGAR | — |
239 total filings indexed. 207 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001014763 |
| Ticker | AIMD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | TX |
| Website | https://www.ainos.com |
| Listed | 1996-08-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report